|
CV surgery: other
Citations 101-110 of 305 total displayed.
|
Past content
(since Feb 1999):
|
- Cell Transplantation and Tissue Regeneration
Protein Precoating of Elastomeric Tissue-Engineering Scaffolds Increased Cellularity, Enhanced Extracellular Matrix Protein Production, and Differentially Regulated the Phenotypes of Circulating Endothelial Progenitor Cells
- Virna L. Sales, George C. Engelmayr, Jr, John A. Johnson, Jr, Jin Gao, Yadong Wang, Michael S. Sacks, and John E. Mayer, Jr
Circulation 2007;116:I-55-63I-, doi:10.1161/CIRCULATIONAHA.106.6806637
[Abstract]
[Full text]
- Myocardial Protection, Perioperative Management, and Vascular Biology
Beneficial Effects of Complement Inhibition With Soluble Complement Receptor 1 (TP10) During Cardiac Surgery: Is There a Gender Difference?
- Harold L. Lazar, Taha Keilani, Carmel A. Fitzgerald, Oz M. Shapira, Curtis T. Hunter, Richard J. Shemin, Henry C. Marsh, Jr, Una S. Ryan, and the TP10 Cardiac Surgery Study Group
Circulation 2007;116:I-83-88I-, doi:10.1161/CIRCULATIONAHA.106.677914
[Abstract]
[Full text]
- Myocardial Protection, Perioperative Management, and Vascular Biology
The Cardiotomy Trial: A Randomized, Double-Blind Study to Assess the Effect of Processing of Shed Blood During Cardiopulmonary Bypass on Transfusion and Neurocognitive Function
- Fraser D. Rubens, Munir Boodhwani, Thierry Mesana, Denise Wozny, George Wells, Howard J. Nathan on behalf of the Cardiotomy Investigators
Circulation 2007;116:I-89-97I-, doi:10.1161/CIRCULATIONAHA.106.678987
[Abstract]
[Full text]
- Myocardial Protection, Perioperative Management, and Vascular Biology
Low Dose Nesiritide and the Preservation of Renal Function in Patients With Renal Dysfunction Undergoing Cardiopulmonary-Bypass Surgery: A Double-Blind Placebo-Controlled Pilot Study
- Horng H. Chen, Thoralf M. Sundt, David J. Cook, Denise M. Heublein, and John C Burnett, Jr
Circulation 2007;116:I-134-138I-, doi:10.1161/CIRCULATIONAHA.106.697250
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
- Barry J. Maron
Circulation 2007;116:196-206, doi:10.1161/CIRCULATIONAHA.107.691378
[Full text]
- Controversies in Cardiovascular Medicine
Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy
- Michael A. Fifer
Circulation 2007;116:207-216, doi:10.1161/CIRCULATIONAHA.107.688135
[Full text]
- Images in Cardiovascular Medicine
Anaphylaxis and Recurrent Hydatid Disease
- Ignacio Cruz-Gonzalez, Francisco Martin-Herrero, Jose M. Gonzalez-Santos, Jose A. Gutierrez-Diez, Maria Sanchez-Ledesma, and Andrew O. Maree
Circulation 2007;115:e643-645e, doi:10.1161/CIRCULATIONAHA.106.684126
[Full text]
- Editorials
Valid Comparisons of Antifibrinolytic Agents Used in Cardiac Surgery
- Charles R. Bridges
Circulation 2007;115:2790-2792, doi:10.1161/CIRCULATIONAHA.107.706598
[Full text]
- Images in Cardiovascular Medicine
A Magic Bullet Through the Heart
- Numan Ali Aydemir, Ihsan Bakir, Firat Altin, Sinan Sahin, and Mehmet Salih Bilal
Circulation 2007;115:e467-468e, doi:10.1161/CIRCULATIONAHA.106.676080
[Full text]
- Images in Cardiovascular Medicine
Left Atrial–Esophageal Fistula After Pulmonary Vein Isolation: A Cautionary Tale
- Andre D’Avila, Leon M. Ptaszek, Paul B. Yu, Jennifer D. Walker, Cameron Wright, Peter A. Noseworthy, Andrea Myers, Marwan Refaat, and Jeremy N. Ruskin
Circulation 2007;115:e432-433e, doi:10.1161/CIRCULATIONAHA.106.680181
[Full text]
|
|
